Global Vendor Neutral Archive (VNA) and PACS Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cloud-hosted
1.2.3 On-Site (Premise)
1.2.4 Hybrid
1.3 Market by Application
1.3.1 Global Vendor Neutral Archive (VNA) and PACS Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Enterprise
1.3.3 Cardiology
1.3.4 Radiology
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vendor Neutral Archive (VNA) and PACS Market Size (2017-2028)
2.2 Vendor Neutral Archive (VNA) and PACS Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Vendor Neutral Archive (VNA) and PACS Market Size by Region (2017-2022)
2.4 Global Vendor Neutral Archive (VNA) and PACS Market Size Forecast by Region (2023-2028)
2.5 Global Top Vendor Neutral Archive (VNA) and PACS Countries Ranking by Market Size
3 Vendor Neutral Archive (VNA) and PACS Competitive by Company
3.1 Global Vendor Neutral Archive (VNA) and PACS Revenue by Players
3.1.1 Global Vendor Neutral Archive (VNA) and PACS Revenue by Players (2017-2022)
3.1.2 Global Vendor Neutral Archive (VNA) and PACS Market Share by Players (2017-2022)
3.2 Global Vendor Neutral Archive (VNA) and PACS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Vendor Neutral Archive (VNA) and PACS Revenue
3.4 Global Vendor Neutral Archive (VNA) and PACS Market Concentration Ratio
3.4.1 Global Vendor Neutral Archive (VNA) and PACS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vendor Neutral Archive (VNA) and PACS Revenue in 2021
3.5 Global Vendor Neutral Archive (VNA) and PACS Key Players Head office and Area Served
3.6 Key Players Vendor Neutral Archive (VNA) and PACS Product Solution and Service
3.7 Date of Enter into Vendor Neutral Archive (VNA) and PACS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vendor Neutral Archive (VNA) and PACS Breakdown Data by Type
4.1 Global Vendor Neutral Archive (VNA) and PACS Historic Revenue by Type (2017-2022)
4.2 Global Vendor Neutral Archive (VNA) and PACS Forecasted Revenue by Type (2023-2028)
5 Global Vendor Neutral Archive (VNA) and PACS Breakdown Data by Application
5.1 Global Vendor Neutral Archive (VNA) and PACS Historic Market Size by Application (2017-2022)
5.2 Global Vendor Neutral Archive (VNA) and PACS Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022)
6.2 North America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
6.3 North America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
6.4 North America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022)
7.2 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
7.3 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
7.4 Europe Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022)
8.2 Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
8.3 Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
8.4 Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022)
9.2 Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
9.3 Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
9.4 Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022)
10.2 Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2028)
10.3 Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2028)
10.4 Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Agfa Healthcare NV
11.1.1 Agfa Healthcare NV Company Details
11.1.2 Agfa Healthcare NV Business Overview
11.1.3 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Products and Services
11.1.4 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.1.5 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.1.6 Agfa Healthcare NV Recent Developments
11.2 Dell Technologies
11.2.1 Dell Technologies Company Details
11.2.2 Dell Technologies Business Overview
11.2.3 Dell Technologies Vendor Neutral Archive (VNA) and PACS Products and Services
11.2.4 Dell Technologies Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.2.5 Dell Technologies Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.2.6 Dell Technologies Recent Developments
11.3 Fujifilm Holdings Corporation
11.3.1 Fujifilm Holdings Corporation Company Details
11.3.2 Fujifilm Holdings Corporation Business Overview
11.3.3 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Products and Services
11.3.4 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.3.5 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.3.6 Fujifilm Holdings Corporation Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Vendor Neutral Archive (VNA) and PACS Products and Services
11.4.4 GE Healthcare Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.4.5 GE Healthcare Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.4.6 GE Healthcare Recent Developments
11.5 IBM Corporation
11.5.1 IBM Corporation Company Details
11.5.2 IBM Corporation Business Overview
11.5.3 IBM Corporation Vendor Neutral Archive (VNA) and PACS Products and Services
11.5.4 IBM Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.5.5 IBM Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.5.6 IBM Corporation Recent Developments
11.6 Koninklijke Philips NV
11.6.1 Koninklijke Philips NV Company Details
11.6.2 Koninklijke Philips NV Business Overview
11.6.3 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Products and Services
11.6.4 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.6.5 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.6.6 Koninklijke Philips NV Recent Developments
11.7 Lexmark International
11.7.1 Lexmark International Company Details
11.7.2 Lexmark International Business Overview
11.7.3 Lexmark International Vendor Neutral Archive (VNA) and PACS Products and Services
11.7.4 Lexmark International Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.7.5 Lexmark International Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.7.6 Lexmark International Recent Developments
11.8 McKesson Corporation
11.8.1 McKesson Corporation Company Details
11.8.2 McKesson Corporation Business Overview
11.8.3 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Products and Services
11.8.4 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.8.5 McKesson Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.8.6 McKesson Corporation Recent Developments
11.9 Novarad Corporation
11.9.1 Novarad Corporation Company Details
11.9.2 Novarad Corporation Business Overview
11.9.3 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Products and Services
11.9.4 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.9.5 Novarad Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.9.6 Novarad Corporation Recent Developments
11.10 Siemens
11.10.1 Siemens Company Details
11.10.2 Siemens Business Overview
11.10.3 Siemens Vendor Neutral Archive (VNA) and PACS Products and Services
11.10.4 Siemens Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.10.5 Siemens Vendor Neutral Archive (VNA) and PACS SWOT Analysis
11.10.6 Siemens Recent Developments
11.11 TeraMedica
11.11.1 TeraMedica Company Details
11.11.2 TeraMedica Business Overview
11.11.3 TeraMedica Vendor Neutral Archive (VNA) and PACS Products and Services
11.11.4 TeraMedica Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.11.5 TeraMedica Recent Developments
11.12 Merge Health
11.12.1 Merge Health Company Details
11.12.2 Merge Health Business Overview
11.12.3 Merge Health Vendor Neutral Archive (VNA) and PACS Products and Services
11.12.4 Merge Health Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.12.5 Merge Health Recent Developments
11.13 BridgeHead
11.13.1 BridgeHead Company Details
11.13.2 BridgeHead Business Overview
11.13.3 BridgeHead Vendor Neutral Archive (VNA) and PACS Products and Services
11.13.4 BridgeHead Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.13.5 BridgeHead Recent Developments
11.14 Carestream Health
11.14.1 Carestream Health Company Details
11.14.2 Carestream Health Business Overview
11.14.3 Carestream Health Vendor Neutral Archive (VNA) and PACS Products and Services
11.14.4 Carestream Health Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
11.14.5 Carestream Health Recent Developments
12 Vendor Neutral Archive (VNA) and PACS Market Dynamics
12.1 Vendor Neutral Archive (VNA) and PACS Market Trends
12.2 Vendor Neutral Archive (VNA) and PACS Market Drivers
12.3 Vendor Neutral Archive (VNA) and PACS Market Challenges
12.4 Vendor Neutral Archive (VNA) and PACS Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cloud-hosted
Table 3. Key Players of On-Site (Premise)
Table 4. Key Players of Hybrid
Table 5. Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Vendor Neutral Archive (VNA) and PACS Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Vendor Neutral Archive (VNA) and PACS Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Region (2017-2022)
Table 9. Global Vendor Neutral Archive (VNA) and PACS Revenue by Players (2017-2022) & (US$ Million)
Table 10. Global Vendor Neutral Archive (VNA) and PACS Market Share by Players (2017-2022)
Table 11. Global Top Vendor Neutral Archive (VNA) and PACS Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vendor Neutral Archive (VNA) and PACS as of 2021)
Table 12. Ranking of Global Top Vendor Neutral Archive (VNA) and PACS Companies by Revenue (US$ Million) in 2021
Table 13. Global 5 Largest Players Market Share by Vendor Neutral Archive (VNA) and PACS Revenue (CR5 and HHI) & (2017-2022)
Table 14. Key Players Headquarters and Area Served
Table 15. Key Players Vendor Neutral Archive (VNA) and PACS Product Solution and Service
Table 16. Date of Key Manufacturers Enter into Vendor Neutral Archive (VNA) and PACS Market
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Vendor Neutral Archive (VNA) and PACS Market Size by Type (2017-2022) & (US$ Million)
Table 19. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2017-2022)
Table 20. Global Vendor Neutral Archive (VNA) and PACS Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 21. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2023-2028)
Table 22. Global Vendor Neutral Archive (VNA) and PACS Market Size by Application (2017-2022) & (US$ Million)
Table 23. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2022)
Table 24. Global Vendor Neutral Archive (VNA) and PACS Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 25. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2023-2028)
Table 26. North America Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022) & (US$ Million)
Table 27. North America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (US$ Million)
Table 28. North America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (US$ Million)
Table 29. North America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (US$ Million)
Table 30. North America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (US$ Million)
Table 31. North America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (US$ Million)
Table 32. North America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (US$ Million)
Table 33. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022) & (US$ Million)
Table 34. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (US$ Million)
Table 35. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (US$ Million)
Table 36. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (US$ Million)
Table 37. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (US$ Million)
Table 38. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (US$ Million)
Table 39. Europe Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (US$ Million)
Table 40. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022) & (US$ Million)
Table 41. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (US$ Million)
Table 42. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (US$ Million)
Table 43. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (US$ Million)
Table 44. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (US$ Million)
Table 45. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Region (2017-2022) & (US$ Million)
Table 46. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue by Region (2023-2028) & (US$ Million)
Table 47. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022) & (US$ Million)
Table 48. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (US$ Million)
Table 49. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (US$ Million)
Table 50. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (US$ Million)
Table 51. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (US$ Million)
Table 52. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (US$ Million)
Table 53. Latin America Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (US$ Million)
Table 54. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Company (2020-2022) & (US$ Million)
Table 55. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue by Country (2023-2028) & (US$ Million)
Table 61. Agfa Healthcare NV Company Details
Table 62. Agfa Healthcare NV Business Overview
Table 63. Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product and Services
Table 64. Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 65. Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 66. Agfa Healthcare NV Recent Developments
Table 67. Dell Technologies Company Details
Table 68. Dell Technologies Business Overview
Table 69. Dell Technologies Vendor Neutral Archive (VNA) and PACS Product and Services
Table 70. Dell Technologies Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 71. Dell Technologies Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 72. Dell Technologies Recent Developments
Table 73. Fujifilm Holdings Corporation Company Details
Table 74. Fujifilm Holdings Corporation Business Overview
Table 75. Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product and Services
Table 76. Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 77. Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 78. Fujifilm Holdings Corporation Recent Developments
Table 79. GE Healthcare Company Details
Table 80. GE Healthcare Business Overview
Table 81. GE Healthcare Vendor Neutral Archive (VNA) and PACS Product and Services
Table 82. GE Healthcare Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 83. GE Healthcare Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 84. GE Healthcare Recent Developments
Table 85. IBM Corporation Company Details
Table 86. IBM Corporation Business Overview
Table 87. IBM Corporation Vendor Neutral Archive (VNA) and PACS Product and Services
Table 88. IBM Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 89. IBM Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 90. IBM Corporation Recent Developments
Table 91. Koninklijke Philips NV Company Details
Table 92. Koninklijke Philips NV Business Overview
Table 93. Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product and Services
Table 94. Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 95. Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 96. Koninklijke Philips NV Recent Developments
Table 97. Lexmark International Company Details
Table 98. Lexmark International Business Overview
Table 99. Lexmark International Vendor Neutral Archive (VNA) and PACS Product and Services
Table 100. Lexmark International Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 101. Lexmark International Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 102. Lexmark International Recent Developments
Table 103. McKesson Corporation Company Details
Table 104. McKesson Corporation Business Overview
Table 105. McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product and Services
Table 106. McKesson Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 107. McKesson Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 108. McKesson Corporation Recent Developments
Table 109. Novarad Corporation Company Details
Table 110. Novarad Corporation Business Overview
Table 111. Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product and Services
Table 112. Novarad Corporation Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 113. Novarad Corporation Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 114. Novarad Corporation Recent Developments
Table 115. Siemens Company Details
Table 116. Siemens Business Overview
Table 117. Siemens Vendor Neutral Archive (VNA) and PACS Product and Services
Table 118. Siemens Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 119. Siemens Vendor Neutral Archive (VNA) and PACS SWOT Analysis
Table 120. Siemens Recent Developments
Table 121. TeraMedica Company Details
Table 122. TeraMedica Business Overview
Table 123. TeraMedica Vendor Neutral Archive (VNA) and PACS Product and Services
Table 124. TeraMedica Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 125. TeraMedica Recent Developments
Table 126. Merge Health Company Details
Table 127. Merge Health Business Overview
Table 128. Merge Health Vendor Neutral Archive (VNA) and PACS Product and Services
Table 129. Merge Health Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 130. Merge Health Recent Developments
Table 131. BridgeHead Company Details
Table 132. BridgeHead Business Overview
Table 133. BridgeHead Vendor Neutral Archive (VNA) and PACS Product and Services
Table 134. BridgeHead Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 135. BridgeHead Recent Developments
Table 136. Carestream Health Company Details
Table 137. Carestream Health Business Overview
Table 138. Carestream Health Vendor Neutral Archive (VNA) and PACS Product and Services
Table 139. Carestream Health Vendor Neutral Archive (VNA) and PACS Revenue in Vendor Neutral Archive (VNA) and PACS Business (2017-2022) & (US$ Million)
Table 140. Carestream Health Recent Developments
Table 141. Vendor Neutral Archive (VNA) and PACS Market Trends
Table 142. Vendor Neutral Archive (VNA) and PACS Market Drivers
Table 143. Vendor Neutral Archive (VNA) and PACS Market Challenges
Table 144. Vendor Neutral Archive (VNA) and PACS Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Vendor Neutral Archive (VNA) and PACS Sales Market Share by Type: 2021 VS 2028
Figure 2. Cloud-hosted Features
Figure 3. On-Site (Premise) Features
Figure 4. Hybrid Features
Figure 5. Global Vendor Neutral Archive (VNA) and PACS Sales Market Share by Application: 2021 VS 2028
Figure 6. Enterprise Case Studies
Figure 7. Cardiology Case Studies
Figure 8. Radiology Case Studies
Figure 9. Vendor Neutral Archive (VNA) and PACS Report Years Considered
Figure 10. Global Vendor Neutral Archive (VNA) and PACS Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Vendor Neutral Archive (VNA) and PACS Market Size 2017-2028 (US$ Million)
Figure 12. Global Vendor Neutral Archive (VNA) and PACS Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Vendor Neutral Archive (VNA) and PACS Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Vendor Neutral Archive (VNA) and PACS Market Share by Players in 2021
Figure 16. Global Top Vendor Neutral Archive (VNA) and PACS Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vendor Neutral Archive (VNA) and PACS as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Vendor Neutral Archive (VNA) and PACS Revenue in 2021
Figure 18. North America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Company in 2021
Figure 19. North America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2017-2028)
Figure 20. North America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2028)
Figure 21. North America Vendor Neutral Archive (VNA) and PACS Revenue Share by Country (2017-2028)
Figure 22. U.S. Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Company in 2021
Figure 25. Europe Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2017-2028)
Figure 26. Europe Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2028)
Figure 27. Europe Vendor Neutral Archive (VNA) and PACS Revenue Share by Country (2017-2028)
Figure 28. Germany Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 29. France Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Vendor Neutral Archive (VNA) and PACS Revenue Share by Region (2017-2028)
Figure 37. China Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 40. India Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Company in 2021
Figure 49. Latin America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Vendor Neutral Archive (VNA) and PACS Revenue Share by Country (2017-2028)
Figure 52. Mexico Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Revenue Share by Country (2017-2028)
Figure 59. Turkey Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Vendor Neutral Archive (VNA) and PACS Revenue (2017-2028) & (US$ Million)
Figure 62. Agfa Healthcare NV Revenue Growth Rate in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
Figure 63. Dell Technologies Revenue Growth Rate in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
Figure 64. Fujifilm Holdings Corporation Revenue Growth Rate in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
Figure 65. GE Healthcare Revenue Growth Rate in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
Figure 66. IBM Corporation Revenue Growth Rate in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
Figure 67. Koninklijke Philips NV Revenue Growth Rate in Vendor Neutral Archive (VNA) and PACS Business (2017-2022)
Figure 68. Lexmark International Revenue Growth Rate in Vendor Neutral Archive (VNA)